Search Results - "DURANTE‐MANGONI, E."

Refine Results
  1. 1

    Infective Endocarditis in the Elderly: Diagnostic and Treatment Options by Ursi, M. P., Durante Mangoni, E., Rajani, R., Hancock, J., Chambers, J. B., Prendergast, B.

    Published in Drugs & aging (01-02-2019)
    “…Infective endocarditis (IE) is an uncommon, life-threatening systemic disorder with significant morbidity and persistently high mortality. The age of the peak…”
    Get full text
    Journal Article
  2. 2

    Management of carbapenem-resistant Enterobacteriaceae infections by Durante-Mangoni, E., Andini, R., Zampino, R.

    Published in Clinical microbiology and infection (01-08-2019)
    “…Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly…”
    Get full text
    Journal Article
  3. 3

    Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patients by DURANTEMANGONI, E., ZAMPINO, R., MARRONE, A., TRIPODI, M.‐F., RINALDI, L., RESTIVO, L., CIOFFI, M., RUGGIERO, G., ADINOLFI, L. E.

    Published in Alimentary pharmacology & therapeutics (01-11-2006)
    “…Summary Background Steatosis and insulin resistance (IR) have a pathogenic role in chronic hepatitis C (HCV). Adipocytokines balance modulates hepatic lipid…”
    Get full text
    Journal Article
  4. 4

    Review article: hepatitis C virus‐associated steatosis – pathogenic mechanisms and clinical implications by ADINOLFI, L. E., DURANTEMANGONI, E., ZAMPINO, R., RUGGIERO, G.

    Published in Alimentary pharmacology & therapeutics (01-11-2005)
    “…Summary Steatosis is a common feature of chronic hepatitis C, and may be caused directly by the virus, as in genotype 3 infection, or be associated with host…”
    Get full text
    Journal Article
  5. 5

    In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis by Tripodi, M.-F., Durante-Mangoni, E., Fortunato, R., Cuccurullo, S., Mikami, Y., Farina, C., Utili, R.

    Published in Transplant infectious disease (01-08-2011)
    “…M.‐F. Tripodi, E. Durante‐Mangoni, R. Fortunato, S. Cuccurullo, Y. Mikami, C. Farina, R. Utili. In vitro activity of multiple antibiotic combinations against…”
    Get full text
    Journal Article
  6. 6

    Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients by Durante-Mangoni, E., Vitrone, M., Parrella, A., Andini, R., Iossa, D., Ragone, E., Falco, E., Maiello, C., Utili, R., Zampino, R.

    Published in Transplant infectious disease (01-06-2016)
    “…Background Treatment of chronic hepatitis B (CHB) with polymerase inhibitors is key to prevent disease flares and progression toward advanced liver disease…”
    Get full text
    Journal Article
  7. 7

    Streptococcus bovis Endocarditis and Its Association with Chronic Liver Disease: An Underestimated Risk Factor by Tripodi, M. F., Adinolfi, L. E., Ragone, E., Mangoni, E. Durante, Fortunato, R., Iarussi, D., Ruggiero, G., Utili, R.

    Published in Clinical infectious diseases (15-05-2004)
    “…Clinical and epidemiological characteristics of Streptococcus bovis endocarditis were prospectively studied among 199 patients with definite endocarditis…”
    Get full text
    Journal Article
  8. 8

    Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients by Zampino, R., Ingrosso, D., Durante-Mangoni, E., Capasso, R., Tripodi, M.-F., Restivo, L., Zappia, V., Ruggiero, G., Adinolfi, L. E.

    Published in Journal of viral hepatitis (01-10-2008)
    “…(A) A reduced activity of microsomal triglyceride transfer protein (MTP), a key enzyme of assembly/secretion of lipoproteins, is related to HCV steatosis. Host…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Drugs and liver injury: a not to be overlooked binomial in COVID-19 by Vitrone, M., Mele, F., Durante-Mangoni, E., Zampino, R.

    Published in Journal of chemotherapy (Florence) (19-05-2022)
    “…SARS-CoV-2 infection (COVID-19) results predominantly in pulmonary involvement but a direct, virus-induced liver damage may also occur, whose mechanisms are…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis by Leone, S., Ravasio, V., Durante-Mangoni, E., Crapis, M., Carosi, G., Scotton, P. G., Barzaghi, N., Falcone, M., Chinello, P., Pasticci, M. B., Grossi, P., Utili, R., Viale, P., Rizzi, M., Suter, F.

    Published in Infection (01-10-2012)
    “…Background The characteristics of patients with infective endocarditis (IE) vary significantly by region of the world. The aim of this study was to evaluate…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Yellow nail syndrome as a cause of unexplained edema by Cimini, C, Giunta, R, Utili, R, Durante-Mangoni, E

    Published in Monaldi archives for chest disease (01-12-2009)
    “…Yellow nail syndrome is a rare cause of edema due to a disordered lymphatic drainage. We recently observed two cases of long-standing, chronic edema, whose…”
    Get full text
    Journal Article
  18. 18
  19. 19

    High-Dose Daptomycin for Cardiac Implantable Electronic Device-Related Infective Endocarditis by Durante-Mangoni, Emanuele, Casillo, Roberta, Bernardo, Mariano, Caianiello, Cristina, Mattucci, Irene, Pinto, Daniela, Agrusta, Federica, Caprioli, Roberta, Albisinni, Rosina, Ragone, Enrico, Utili, Riccardo

    Published in Clinical infectious diseases (01-02-2012)
    “…Background. Cardiac implantable electronic device (CIED)-related endocarditis is a growing challenge because of increasing incidence and significant mortality…”
    Get full text
    Journal Article
  20. 20